BRIANNA QUINN: Open Payments
NPI 1477828291 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 32 payments from 14 companies in 2025. Trend: 2023 $2,670 · 2024 $296 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $208 |
| EMD Serono, Inc. | 3 | $176 |
| Medtronic, Inc. | 1 | $72 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Lundbeck LLC | 2 | $62 |
| ARGENX US, INC. | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| PFIZER INC. | 2 | $46 |
| UCB, Inc. | 1 | $45 |
| TG Therapeutics, Inc. | 1 | $31 |
Products named: BOTOX, PROPEL, KESIMPTA, QULIPTA, VYEPTI, VYVGART HYTRULO, REXULTI, UBRELVY.
Industry payments across FL — which companies pay providers there.
